Antiproliferative effects of sorafenib and pegylated IFN-α2b on human liver cancer cells in vitro and in vivo

Novel therapeutic strategies are needed to treat patients with advanced hepatocellular carcinoma (HCC). Combination therapy of sorafenib and type I interferon (IFN) has substantial activity in patients with metastatic renal cell carcinoma. We investigated the antiproliferative effects of sorafenib i...

Descripción completa

Detalles Bibliográficos
Autores principales: KUSANO, HIRONORI, OGASAWARA, SACHIKO, AKIBA, JUN, NAKAYAMA, MASAMICHI, UEDA, KOSUKE, YANO, HIROHISA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699579/
https://www.ncbi.nlm.nih.gov/pubmed/23588838
http://dx.doi.org/10.3892/ijo.2013.1904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699579/
https://www.ncbi.nlm.nih.gov/pubmed/23588838
http://dx.doi.org/10.3892/ijo.2013.1904

Ejemplares similares